Chest Shielding in Premature Infants During Phototherapy



Status:Active, not recruiting
Conditions:Cardiology, Women's Studies
Therapuetic Areas:Cardiology / Vascular Diseases, Reproductive
Healthy:No
Age Range:Any
Updated:2/17/2019
Start Date:August 1, 2015
End Date:June 2020

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Effect of Chest Shielding on the Incidence of Patent Ductus Arteriosus in Premature Infants Undergoing Phototherapy

Infants will be randomized to either chest shielding with aluminum foil or chest shielding
without aluminum foil while undergoing phototherapy for premature infants. The primary
outcome is patent ductus arteriosus.


Inclusion Criteria:

- less or equal to 29 weeks or 1000g at birth

- Admitted to the NICU (Neonatal intensive care unit) within 24 hours after birth

- English speaking parents

Exclusion Criteria:

- Congenital abnormalities

- Chromosomal disorders

- Cyanotic heart defects

- Nitric oxide

- Prophylactic phototherapy

- Unlikely to survive beyond 72 hours according to the attending neonatologist

- Do not require phototherapy
We found this trial at
1
site
University of Rochester
60 Crittenden Blvd # 70
Rochester, New York 14642
(585) 275-2121
Principal Investigator: Sanjiv Amin, MD, MS
Phone: 585-273-2696
University of Rochester The University of Rochester is one of the country's top-tier research universities....
?
mi
from
Rochester, NY
Click here to add this to my saved trials